Bone-conducted ultrasonic auditory brainstem response thresholds in a mouse model of cisplatin-induced hearing loss
PLOS One · 2026
DOI: 10.1371/journal.pone.0353954 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Akihito Nakanishi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biological Principles, Department of Physiology and Biophysics, Graduate School of Medicine, Gifu University, 1-1 Yanagido, Gifu, Japan. Hauptthemen laut MEDLINE: Cisplatin, Evoked Potentials, Auditory, Brain Stem, Auditory Threshold, Hearing Loss. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Suzuken Memorial Foundation, Naito Foundation, Terumo Foundation for Life Sciences and Arts.
Abstract (Originalsprache)
Cisplatin is widely used in cancer treatment but can cause hearing loss, predominantly at high frequencies. Auditory responses to bone-conducted ultrasonic stimulation have been proposed as a potential indicator of cochlear function, but it remains unclear how such responses are affected by cochlear damage. In this study, we measured auditory brainstem response (ABR) thresholds within and beyond the conventional hearing range in a mouse model of cisplatin-induced hearing loss. Of 32 mice initially examined, 9 were excluded at baseline because of pre-existing high-frequency hearing impairment. The remaining animals received either saline or cisplatin, and post-treatment analysis in the cisplatin group was based on 16 surviving mice. Cisplatin administration increased ABR thresholds within the conventional hearing range. In contrast, threshold shifts evoked by bone-conducted ultrasonic stimulation were often smaller. Paired comparison of mean threshold shifts showed that changes evoked by bone-conducted ultrasonic stimulation were significantly smaller than those within the conventional hearing range. These findings show that ABR threshold shifts evoked by bone-conducted ultrasonic stimulation do not necessarily parallel those within the conventional hearing range in cisplatin-treated mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Biological Principles, Department of Physiology and Biophysics, Graduate School of Medicine, Gifu University, 1-1 Yanagido, Gifu, Japan.
- Department of Otolaryngology-Head and Neck Surgery, University of Toyama, Sugitani, Toyama, Japan.
- Division of Sensorimotor Medicine, Department of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Gifu University, 1-1 Yanagido, Gifu, Japan.
ORCID-Profile: Bakushi Ogawa, Kazuhiro Horii, Iori Niitsu Morimoto, Fumiaki Nin
Förderung
- Suzuken Memorial Foundation
- Naito Foundation
- Terumo Foundation for Life Sciences and Arts
- Mitsubishi Foundation
- Takeda Science Foundation
- Ogawa Memorial Foundation
- the Japan Agency for Medical Research and Development
- JST FOREST Program
Zitieren
APA
Nakanishi, A., Nagase, N., Kousaki, H., Ogawa, B., Horii, K., Morimoto, I. N., Morita, Y., & Nin, F. (2026). Bone-conducted ultrasonic auditory brainstem response thresholds in a mouse model of cisplatin-induced hearing loss. PLOS One. https://doi.org/10.1371/journal.pone.0353954
Vancouver
Nakanishi A, Nagase N, Kousaki H, Ogawa B, Horii K, Morimoto IN, et al. Bone-conducted ultrasonic auditory brainstem response thresholds in a mouse model of cisplatin-induced hearing loss. PLOS One. 2026. doi:10.1371/journal.pone.0353954
BibTeX
@article{Nakanishi2026,
author = {Nakanishi, Akihito and Nagase, Noriko and Kousaki, Hirokazu and Ogawa, Bakushi and Horii, Kazuhiro and Morimoto, Iori Niitsu and Morita, Yuka and Nin, Fumiaki},
title = {Bone-conducted ultrasonic auditory brainstem response thresholds in a mouse model of cisplatin-induced hearing loss},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0353954}
}
EUVIMED